← Leaderboards
Peter E Lipsky
University Of Texas Sw Med Ctr/Dallas
$1,069,221
Attributed
$1,069,221
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,069,221 · 2
By mechanism
M01$642,748 · 1
P01$426,473 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Errol Friedberg$5,175,366
- Paula Louise Fischhaber$2,570,022
- Elizabeth Sally Ward$8,676,225
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectPatient Oriented ResearchSystemic Lupus ErythematosusB LymphocyteHuman Therapy EvaluationPathologic ProcessAutoantibodyRheumatoid ArthritisCytokineLeukocyte Activation /TransformationArthritis TherapyTissue /Cell CultureTumor Necrosis Factor AlphaImmunotherapyBiological Signal TransductionAutoimmunityTranscription FactorAntiinflammatory AgentsPsoriasisGene RearrangementImmunoglobulin GenesMonocyteLaboratory MouseDrug Screening /Evaluation
Grant awards (64)
B Cell Repertoire Analysis$1,053,649
Z01 · FY2007 · AR · contact PI
B Cell Signaling$1,053,649
Z01 · FY2007 · AR · contact PI
B Cells and Autoimmunity$757,691
Z01 · FY2007 · AR · contact PI
Active Components Of The Chinese Herbal Remedies$0
Z01 · FY2006 · AR · contact PI
B Cell Signaling$0
Z01 · FY2006 · AR · contact PI
The development of 3-way FRET in detecting three-protein$0
Z01 · FY2006 · AR · contact PI
Animal Models of Autoimmunity$0
Z01 · FY2006 · AR · contact PI
Studies Of Arthritis In Children And Adults$0
Z01 · FY2006 · AR · contact PI
B Cell Repertoire Analysis$0
Z01 · FY2006 · AR · contact PI
Studies Of The Pathogenesis, Natural History & Treatment$0
Z01 · FY2006 · AR · contact PI
Animal Models of Autoimmunity$0
Z01 · FY2005 · AR
Studies Of Arthritis In Children And Adults$0
Z01 · FY2005 · AR
Active Components Of The Chinese Herbal Remedies$0
Z01 · FY2005 · AR
B Cell Signaling$0
Z01 · FY2005 · AR
B Cell Repertoire Analysis$0
Z01 · FY2005 · AR
Pathogenesis, Natural Hist. &Treat. of Lupus Nephritis$0
Z01 · FY2005 · AR
Development of 3-way FRET in detecting three-protein$0
Z01 · FY2005 · AR
Pathogenesis and treatment studies in patients with NOMI$0
Z01 · FY2005 · AR
Pathogenesis/Natural History/Therapy of Lupus Nephritis$0
Z01 · FY2004 · AR
B Cell Repertoire Analysis$0
Z01 · FY2004 · AR
B Cell Signalling$0
Z01 · FY2004 · AR
Pathogenesis And Natural History Of Psoriatic Arthritis$0
Z01 · FY2004 · AR
The study of Exercise Induced Arthritis in Osteopontin k$0
Z01 · FY2004 · AR
Comparative Imaging of the knee in a murine model of ost$0
Z01 · FY2004 · AR
FRET and its application in detecting protein complexes$0
Z01 · FY2004 · AR
Pathogenesis and treatment studies in patients with NOMI$0
Z01 · FY2004 · AR
Animal Models of Autoimmunity$0
Z01 · FY2004 · AR
Studies Of Arthritis In Children And Adults$0
Z01 · FY2004 · AR
Active Components Of The Chinese Herbal Remedies$0
Z01 · FY2004 · AR
Studies Of Arthritis In Children And Adults$0
Z01 · FY2003 · AR
Pathogenesis And Natural History Of Psoriatic Arthritis$0
Z01 · FY2003 · AR
Molecular Determinants Of Skeletal Morphogenesis And Dys$0
Z01 · FY2003 · AR
Studies Of The Pathogenesis, Natural History &Treatment$0
Z01 · FY2003 · AR
B Cell Repertoire Analysis$0
Z01 · FY2003 · AR
B Cell Signalling$0
Z01 · FY2003 · AR
Active Components Of The Chinese Herbal Remedies$0
Z01 · FY2003 · AR
Animal Models of Autoimmunity$0
Z01 · FY2003 · AR
Pathogenesis and treatment studies in patients with NOMI$0
Z01 · FY2003 · AR
ATHEROSCLEROSIS RISK FACTORS IN MINORITY SLE PATIENTS$321,374
M01 · FY2002 · RR
Studies Of Arthritis In Children And Adults$0
Z01 · FY2002 · AR
Active Components Of The Chinese Herbal Remedies$0
Z01 · FY2002 · AR
B Cell Signalling$0
Z01 · FY2002 · AR
B Cell Repertoire Analysis$0
Z01 · FY2002 · AR
Studies Of The Pathogenesis, Natural History &Treatment$0
Z01 · FY2002 · AR
Molecular Determinants Of Skeletal Morphogenesis And Dys$0
Z01 · FY2002 · AR
Pathogenesis And Natural History Of Psoriatic Arthritis$0
Z01 · FY2002 · AR
ATHEROSCLEROSIS RISK FACTORS IN MINORITY SLE PATIENTS$321,374
M01 · FY2001 · RR
IMMUNOGLOBULIN REPERTOIRE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS$247,465
P01 · FY2001 · AI
Active Components Of The Chinese Herbal Remedies$0
Z01 · FY2001 · AR
B Cell Signalling$0
Z01 · FY2001 · AR
B Cell Repertoire Analysis$0
Z01 · FY2001 · AR
Studies Of Arthritis In Children And Adults$0
Z01 · FY2001 · AR
Molecular Determinants Of Skeletal Morphogenesis And Dys$0
Z01 · FY2001 · AR
Pathogenesis And Natural History Of Psoriatic Arthritis$0
Z01 · FY2001 · AR
Studies Of The Pathogenesis, Natural History &Treatment$0
Z01 · FY2001 · AR
IMMUNOGLOBULIN REPERTOIRE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS$179,008
P01 · FY2000 · AI
Active Components of the Chinese Herbal Remedies$0
Z01 · FY2000 · AR
B CELL SIGNALLING$0
Z01 · FY2000 · AR
B CELL REPERTOIRE ANALYSIS$0
Z01 · FY2000 · AR
STUDIES OF THE PATHOGENESIS, NATURAL HISTORY &TREATMENT$0
Z01 · FY2000 · AR
MOLECULAR DETERMINANTS OF SKELETAL MORPHOGENESIS &DYSMO$0
Z01 · FY2000 · AR
STUDIES OF EARLY ARTHRITIS$0
Z01 · FY2000 · AR
PATHOGENESIS AND NATURAL HISTORY OF PSORIATIC ARTHRITIS$0
Z01 · FY2000 · AR
ATHEROSCLEROSIS RISK FACTORS IN MINORITY SLE PATIENTS$0
M01 · FY2000 · RR